撤稿声明：雷帕霉素哺乳动物靶点抑制剂治疗的心脏移植受者伤口并发症发生率：一项荟萃分析。
RETRACTION: Wound Complications Frequency in Heart Transplant Recipients on Mammalian Target of Rapamycin Inhibitors: A Meta-Analysis.
出版信息
Int Wound J. 2025 Feb;22(2):e70208. doi: 10.1111/iwj.70208.
S. Zhu, W. Yu, J. Gao, and J. Xiong, "Wound Complications Frequency in Heart Transplant Recipients on Mammalian Target of Rapamycin Inhibitors: A Meta-Analysis," International Wound Journal 20, no. 9 (2023): 3491-3497, https://doi.org/10.1111/iwj.14221. The above article, published online on 10 May 2023, in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor in Chief, Professor Keith Harding; and John Wiley & Sons Ltd. Following an investigation by the publisher, all parties have concluded that this article was accepted solely on the basis of a compromised peer review process. The editors have therefore decided to retract the article. The authors did not respond to our notice regarding the retraction.
朱思远、余伟、高佳、熊佳，“雷帕霉素哺乳动物靶点抑制剂治疗的心脏移植受者伤口并发症发生率：一项荟萃分析”，《国际伤口杂志》2023年第20卷第9期，第3491 - 3497页，https://doi.org/10.1111/iwj.14221 。上述文章于2023年5月10日在Wiley Online Library（http://onlinelibrary.wiley.com/）在线发表，已根据期刊主编基思·哈丁教授与约翰·威利父子有限公司的协议撤回。经过出版商的调查，各方得出结论，这篇文章完全是基于有缺陷的同行评审过程而被接受的。因此，编辑们决定撤回这篇文章。作者未对我们关于撤回的通知做出回应。
Zotero 插件